AzTrials
AzTrials

Postoperative Cognitive DysfunctionNCT07424729

Minimal-flow Anesthesia and Cognitive Outcomes in Elderly Surgical Patients

A study testing Mini-Mental State Examination in people with Postoperative Cognitive Dysfunction, run by Ankara Etlik City Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose: Postoperative cognitive dysfunction (POCD) is a common complication in elderly patients following major surgery and is associated with impaired attention, memory, and executive functions. Advanced age and prolonged surgical duration are among the most important risk factors. Read more about this study

Who is it for?
Ages 65 to 85 years
Conditions the study is for
Postoperative Cognitive Dysfunction
What is being tested?
Mini-Mental State Examination
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
3 Oct 2025to 15 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 85 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patients aged between 65 and 85 years
  • ASA physical status I-III
  • Scheduled for elective surgery under general anesthesia in general surgery or otorhinolaryngology operating rooms
  • Planned to receive minimal flow general anesthesia
  • Preoperative Mini-Mental State Examination performed
  • Able to provide informed consent

Who cannot join

  • Age outside the specified range
  • ASA physical status IV or higher
  • Severe comorbid disease affecting perioperative stability
  • Surgery performed under regional anesthesia
  • History of alcohol, drug, or substance abuse
  • Significant visual or hearing impairment interfering with cognitive testing
Show all 13Show fewer
  • Refusal to participate
  • Known neurological or psychiatric disorders
  • Preoperative MMSE score below 24
  • Perioperative hemodynamic instability
  • Illiteracy preventing completion of cognitive tests
  • Postoperative admission to intensive care unit
  • -

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ankara Etlik City Hospital

    Yenimahalle, Ankara, 06170

Other trials in Turkey (Türkiye)

About this study

Official title: Minimal-flow Anesthesia, Surgical Duration, and Postoperative Cognitive Dysfunction in Older Patients

Purpose:

Postoperative cognitive dysfunction (POCD) is a common complication in elderly patients following major surgery and is associated with impaired attention, memory, and executive functions. Advanced age and prolonged surgical duration are among the most important risk factors. Minimal flow anesthesia has been suggested to reduce postoperative cognitive impairment by providing more stable anesthetic depth and reducing physiological stress.

The aim of this study is to investigate the relationship between surgical duration and postoperative cognitive dysfunction in elderly patients undergoing surgery under minimal flow anesthesia.

Read the detailed description

Detailed Description:

Postoperative cognitive dysfunction (POCD) is a syndrome characterized by deterioration in cognitive domains such as attention, memory, executive function, and psychomotor speed, particularly in elderly patients after major surgical procedures. POCD may become evident in the early postoperative hours or may present days to weeks after surgery. Its incidence increases with age, prolonged surgical duration, anesthetic technique, comorbid conditions, and perioperative physiological disturbances.

Diagnosis of POCD requires comparison of preoperative baseline cognitive status with postoperative neurocognitive assessments. The Mini-Mental State Examination (MMSE) and the Richmond Agitation-Sedation Scale (RASS) are validated and reliable tools for evaluating cognitive status in the perioperative period.

Minimal flow anesthesia is defined as the use of fresh gas flow rates between 0.25 and 0.5 L/min, allowing partial rebreathing of anesthetic agents. This technique reduces anesthetic consumption, maintains stable anesthetic depth, and preserves temperature and humidity, potentially minimizing physiological stress. Previous studies suggest that minimal flow anesthesia with sevoflurane may be associated with a lower incidence of early postoperative cognitive impairment compared to higher flow techniques.

In this prospective interventional study, patients aged 65-85 years undergoing surgery under minimal flow inhalational anesthesia will be enrolled. Patients will be divided into two groups based on surgical duration: surgeries lasting less than 2 hours and surgeries lasting 2 hours or longer, with 45 patients in each group.

All patients will undergo preoperative cognitive assessment using the MMSE. Standard ASA monitoring and bispectral index (BIS) monitoring will be applied intraoperatively to maintain anesthetic depth between BIS values of 40 and 60. Anesthesia induction and maintenance will be performed using routine anesthetic agents and minimal flow inhalational anesthesia as part of standard clinical practice.

Neuromuscular blockade will be reversed with sugammadex at the end of surgery. Postoperatively, patients will be evaluated using the RASS at the 10th, 30th, and 60th minutes in the recovery room. Neurology consultation will be requested for patients with RASS scores outside the normal range. Vital signs, pain scores (VAS), and blood glucose levels will be recorded during these assessments.

Postoperative cognitive function will be reassessed using the MMSE at 24 hours and on postoperative day 7. Preoperative and postoperative cognitive assessments will be conducted by study investigators who are blinded to surgical duration. The anesthetic management will be performed by anesthesiologists not involved in the study.

The primary objective of this study is to evaluate the association between surgical duration and postoperative cognitive dysfunction in elderly patients undergoing surgery under minimal flow anesthesia.

Being tested
Mini-Mental State Examination
Keywords
Postoperative cognitive dysfunction, Minimal flow anesthesia, Elderly patients, Mini-Mental State Examination, Surgical duration
Medical subject headings
Postoperative Cognitive Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mini-Mental State ExaminationOther

    Also called MMSE

    Cognitive function will be assessed using the Mini-Mental State Examination preoperatively and at postoperative time points.

Study groups in NCT07424729
Study groupRoleWhat they receive
Arm 1: Surgery duration <2 hoursExperimentalElderly patients undergoing surgery under minimal flow anesthesia with a surgical duration of less than 2 hours. Cognitive function will be assessed preoperatively and postoperatively using the Mini-Mental State Examination.
Receives: Other: Mini-Mental State Examination
Arm 2: Surgery duration ≥2 hoursExperimentalElderly patients undergoing surgery under minimal flow anesthesia with a surgical duration of 2 hours or longer. Cognitive function will be assessed preoperatively and postoperatively using the Mini-Mental State Examination.
Receives: Other: Mini-Mental State Examination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Mini-Mental State Examination score

    Cognitive function will be assessed using the Mini-Mental State Examination (MMSE), a 30-point scale ranging from 0 to 30, where higher scores indicate better cognitive function. The primary outcome is the change in MMSE score between the preoperative assessment and postoperative assessments.

    Change in cognitive function assessed by the difference between preoperative and postoperative Mini-Mental State Examination scores.

    Measured: Preoperative baseline, postoperative 24 hours, and postoperative day 7

Secondary outcomes (1)
  1. Incidence of postoperative cognitive dysfunction

    The proportion of patients who develop postoperative cognitive dysfunction based on changes in Mini-Mental State Examination (MMSE) scores. Postoperative cognitive dysfunction will be defined according to a predefined decline in MMSE score compared with the preoperative baseline assessment.

    Measured: Postoperative 24 hours and postoperative day 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2026
  2. Study start3 Oct 2025
  3. Primary completion12 Mar 2026
  4. Study completion15 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Participants will be assigned into two parallel groups according to surgical duration (less than 2 hours or longer) and postoperative cognitive outcomes will be compared between groups.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07424729
Sponsor's protocol ID
AEŞH-EK-2025-187
Status last verified
Mar 2026
First submitted
5 Feb 2026
Last updated
18 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared because the study involves a single-center academic dataset and no data-sharing agreement has been established. De-identified data may be made available upon reasonable request to the principal investigator.

Publications

  • Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M, Eckenhoff RG; Nomenclature Consensus Working Group. Recommendations for the Nomenclature of Cognitive Change Associated with Anaesthesia and Surgery-2018. Anesthesiology. 2018 Nov;129(5):872-879. doi: 10.1097/ALN.0000000000002334.

    PubMed 30325806

Questions about this trial

What is this clinical trial studying?

A study testing Mini-Mental State Examination in people with Postoperative Cognitive Dysfunction, run by Ankara Etlik City Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Mini-Mental State Examination score (time frame: Preoperative baseline, postoperative 24 hours, and postoperative day 7). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07424729, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in